文献速递白血病

识别预测成人急性髓系白血病患者低风险发热性中性粒细胞减少症住院的因素

Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2024-01-01

该研究纳入2016至2023年因发热性中性粒细胞减少症住院的397例次成人高级别髓系肿瘤患者,仅15%为例次为低风险结局。生理参数(心率、血压、发热高度)是低风险住院和感染的最佳预测因素,多变量模型预测低风险住院和感染的AUC分别为0.82和0.72。已有的发热性中性粒细胞减少症和危重症模型对急性髓系白血病结局无预测价值,未能识别低风险组,需开发并验证急性髓系白血病特异性模型。

要点

  • 397例次发热性中性粒细胞减少症住院中仅15%为低风险结局(住院<72小时且未入ICU未院内死亡)。
  • 心率、血压和发热高度等生理参数是低风险住院和感染的最佳预测因素。
  • 已建立的发热性中性粒细胞减少症和危重症模型对急性髓系白血病结局无预测价值,未能识别低风险组。

核心结论

  • 已有的发热性中性粒细胞减少症和危重症模型对急性髓系白血病结局无预测价值,未能识别低风险组。
  • 急性髓系白血病特异性发热性中性粒细胞减少症风险模型需要进一步开发和验证。

研究设计与样本

  • 研究纳入2016至2023年因发热性中性粒细胞减少症住院、接受强化化疗的成人高级别髓系肿瘤(血液/骨髓原始细胞≥10%)患者。
  • 共识别248例患者的397例次发热性中性粒细胞减少症住院,中位年龄61岁(范围29-77岁)。
  • 收集基线临床和疾病变量,采用单变量和多变量逻辑回归模型评估协变量与结局的关联。

主要发现

  • 中位住院时间为6天(范围1-56天),10%的例次需入住ICU,3.5%的例次院内死亡。
  • 仅15%的例次为低风险结局(住院<72小时且未入ICU、未院内死亡),59%的例次识别出感染。
  • 生理参数(包括心率、血压和发热高度)是低风险住院和感染的最佳预测因素。
  • 多变量模型预测低风险住院和感染的曲线下面积(AUC)分别为0.82和0.72。
  • 已建立的发热性中性粒细胞减少症和危重症模型对急性髓系白血病结局无预测价值,未能识别低风险组。

关键数值与推荐

  • 低风险结局定义为住院时间<72小时且未入住ICU、未发生院内死亡。
  • 多变量模型预测低风险住院的AUC为0.82,预测感染的AUC为0.72。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 已有的发热性中性粒细胞减少症和危重症模型对急性髓系白血病结局无预测价值,未能识别低风险组。
  • 急性髓系白血病特异性发热性中性粒细胞减少症风险模型需要进一步开发和验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Febrile neutropenia (FN) is the most common reason for hospital readmission after chemotherapy for acute myeloid leukemia (AML) and is a major driver of health care resource utilization. Although FN risk models exist, they have largely been developed and validated for solid tumors. We therefore examined whether baseline characteristics could predict which patients with AML and FN have a lower risk of progression to severe illness. We identified adults with high-grade myeloid neoplasms (≥10% blasts in the blood/marrow) who received intensive chemotherapy and who were admitted for FN between 2016 and 2023. We collected baseline clinical and disease variables. Outcomes were: infections identified, hospital length of stay (LOS), intensive care unit (ICU) admission, and survival. A lower-risk (LR) outcome was defined as LOS <72 hours without ICU admission or inpatient death. Univariate and multivariable (MV) logistic regression models were used to assess covariate associations with outcomes. We identified 397 FN admissions in 248 patients (median age, 61; [range, 29-77] years). The median hospital LOS was 6 days (range, 1-56) days; 10% required ICU admission, and 3.5% died inpatient. Only 15% of admissions were LR. Infection was identified in 59% of admissions. Physiologic parameters, including heart rate, blood pressure, and fever height, were the best predictors of LR admission and infection. We developed MV models to predict LR admission and infection with area under the curve (AUC) of 0.82 and 0.72, respectively. Established FN and critical illness models were not predictive of outcomes in AML, and we could not identify a LR group; thus, an AML-specific FN risk model requires further development and validation.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Pal KV, Othus M, Ali Z, et al. Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia. Blood Adv. 2024. PMID: 39368804. doi:10.1182/bloodadvances.2024014291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。